Clinical Trial Update: Saracatinib and Alcohol Drinking [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for saracatinib in individuals with alcohol drinking behavior; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder

Drugs mentioned

• Saracatinib (saracatinib)

Snippet

Sponsor: Yale University | Conditions: Alcohol Drinking | Phase 2 | Status: COMPLETED | Results posted: 2020-11-13